Akerna (NASDAQ:KERN) is the parent company resulting from the merger between MJ Freeway and MTech Acquisition Corp., the first US-listed Special Purpose Acquisition Company (SPAC) focused on acquiring a cannabis technology company. Akerna has acquired cash proceeds released from MTechâs trust account and is the first cannabis software company listed on a major U.S. exchange. Akerna consolidates cannabis technology companies to connect data points in the global cannabis supply chain. In doing so, Akerna creates one of the worldâs most transparent and accountable consumer packaged goods supply chain with global scale. We believe connected data and information will modernize and propel the cannabis industry increasing the power of businesses, governments, patients and consumers to make smart decisions. The cornerstone service offerings is MJ Freeway, the worldâs largest, global cannabis software company that invented seed-to-sale tracking and developed the industryâs first cannabis ERP. Established in 2010, MJ Freeway has to date tracked more than $15 billion in legal cannabis sales. Founded in 2010 by technologists creating tech specifically for cannabis businesses, MJ Freewayâs tracking software includes inventory control and grow management applications to streamline workflow and increase efficiency. MJ Freewayâs Leaf Data Systems software solution enables governments to track cannabis plants from seed-to-sale and ensure patient, public, and product safety. MJ Freeway also offers a complete suite of professional consulting services for cannabis businesses. For more information, visit mjfreeway.com. Source
No articles found.
The Hain Celestial Group is a leading organic and natural products company with op...
The Hain Celestial Group is a leading organic a...
Located in Williamsburg, Virginia, Eight Shires Distillery is on a mission to âr...
Located in Williamsburg, Virginia, Eight Shires...
Elevate is the first of its kind, a line of high-performance nutritional supplemen...
Elevate is the first of its kind, a line of hig...
Therapix Biosciences Ltd. (NASDAQ: TRPX) is a specialty clinical-stage pharmaceuti...
Therapix Biosciences Ltd. (NASDAQ: TRPX) is a s...
Join the National Investor Network and get the latest information with your interests in mind.